Zobrazeno 1 - 10
of 4 556
pro vyhledávání: '"thymic carcinoma"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-24 (2024)
Abstract This study aims to clarify the impact of tumor size on the prognosis of patients diagnosed with thymoma and thymic carcinoma, leveraging data from a population-based registry. Utilizing the SEER database, this retrospective analysis identifi
Externí odkaz:
https://doaj.org/article/5ecf8dc9a06d467bb2f01ce557440f42
Autor:
Gizem Özçıbık Işık, Akif Turna
Publikováno v:
Frontiers in Surgery, Vol 11 (2024)
Thymic epithelial tumors originate from the epithelial cells of the thymus and are typically diagnosed during the 5th and 6th decades of life. The incidence is consistent between men and women, averaging 1.7 cases per year. Thymomas, neuroendocrine t
Externí odkaz:
https://doaj.org/article/8cee50333c084a5f91366555df84b6ac
Autor:
Mariana Agudelo-Arrieta, María Isabel Ocampo-Navia, María Carolina Martínez, María Paula Rodríguez, Isabella Lacouture, Luis Fernando Jaramillo, Eugenio Meek, Oscar Feo-Lee
Publikováno v:
Brain Disorders, Vol 15, Iss , Pp 100154- (2024)
Thymic squamous cell carcinoma (TSCC) is a rare cancer that is typically characterized by low rates of brain metastases. However, when it does occur, brain metastases of TSCC can have significant clinical implications due to its rarity and lack of es
Externí odkaz:
https://doaj.org/article/891858f66b8c4d5896a132c7a85d5e68
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 5, Iss 3, Pp 465-476 (2024)
Thymic epithelial tumors (TETs) are rare malignant neoplasms arising in the thymus gland. Nevertheless, TETs, including thymomas (TMs), thymic carcinomas (TCs), and thymic neuroendocrine neoplasms (TNENs), are the most common mediastinal malignancies
Externí odkaz:
https://doaj.org/article/cc87dadfdb604b4684fe4d444588e997
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-6 (2024)
Abstract Introduction Surgery remains the primary treatment modality for thymic carcinoma, with adjuvant radiotherapy being recommended to effectively mitigate local recurrence and metastasis rates subsequent to incomplete or complete resection. Chem
Externí odkaz:
https://doaj.org/article/f1b65a9b509b4825a247a91ce3fbbe95
Autor:
Anne S. Tsao, MD, MBA, Ming-Hui Hsieh, MS, Marianna Koczywas, MD, Janet Tu, MD, Jonathan Riess, MD, MS, Tawee Tanvetyanon, MD, Barbara T. Ma, MD, Ying-Qi Zhao, PhD, Mary W. Redman, PhD, Martin J. Edelman, MD, David R. Gandara, MD, Jhanelle E. Gray, MD, Karen L. Kelly, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 12, Pp 100738- (2024)
Introduction: Thymic carcinoma is a rare and aggressive malignancy with few treatment options. Preclinical studies suggested that targeting the angiogenic pathway may be beneficial in this disease. Methods: This randomized phase 2 trial enrolled pati
Externí odkaz:
https://doaj.org/article/7f396844a1284e749b281a3b1ccd70fc
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 16, Iss , Pp 100323- (2024)
Objectives: Thymic carcinoma (TC) is rare. There is no evidence regarding the treatment strategies for unresectable locally advanced thymic carcinomas. Definitive chemoradiotherapy may treat this condition. However, an appropriate concurrent chemothe
Externí odkaz:
https://doaj.org/article/efb806ab73064b52b17b367502f96978
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Thymic carcinoma (TC) is an uncommon type of thymic epithelial tumors. Patients with relapsed or refractory TCs have a poor prognosis. Immune checkpoint inhibitor monotherapy can be applied as a second-line treatment for such cases. This study report
Externí odkaz:
https://doaj.org/article/dae94c98f3bd4af7994e6ad314b247ed
Autor:
Kana Kurokawa, MD, PhD, Tetsuhiko Asao, MD, PhD, Takuo Hayashi, MD, PhD, Satsuki Kishikawa, MD, PhD, Koichiro Kanamori, MD, PhD, Takehito Shukuya, MD, PhD, Yosuke Miyashita, MD, Ikuko Nakamura, MD, PhD, Taichi Miyawaki, MD, PhD, Ryota Kanemaru, MD, PhD, Tomoyasu Mimori, MD, PhD, Yoichiro Mitsuishi, MD, PhD, Ken Tajima, MD, PhD, Naoko Shimada, MD, PhD, Fumiyuki Takahashi, MD, PhD, Kazuya Takamochi, MD, PhD, Kenji Suzuki, MD, PhD, Kazuhisa Takahashi, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 7, Pp 100693- (2024)
Introduction: Trophoblast cell surface antigen 2 (TROP2) is a transmembrane glycoprotein overexpressed in various cancer types. Although TROP2-targeting therapy is currently attracting attention, little is known about TROP2 expression in thymic carci
Externí odkaz:
https://doaj.org/article/526c290b37624cbab22dad2c640df319
Autor:
Ioanna Kantzou, Georgios Sarris, Vasileios Kouloulias, Ioannis Abatzoglou, Vasileios Leivaditis, Konstantinos Grapatsas, Efstratios Koletsis, Athanasios Papatriantafyllou, Manfred Dahm, Admir Mulita, Francesk Mulita, Nikolaos Baltayiannis
Publikováno v:
Polish Journal of Thoracic and Cardiovascular Surgery, Vol 20, Iss 4, Pp 255-262 (2024)
Mediastinal tumors encompass a diverse range of malignancies, originating within or spreading to the mediastinum. The administration of radiotherapy within the anatomical confines of the mediastinum presents unique challenges owing to the close proxi
Externí odkaz:
https://doaj.org/article/215751040aa44ac88522b0c668e3565a